Patent · US Active

Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen as diagnostic and therapeutic tools for prostate cancer

US8632777B2 · kind B2 · utility

3Cited by

3References

6Claims

0Family size

Assignee

UNIVERSITAETSKLINIKUM FREIBURG · DE

Inventors

Ursula Elsässer-Beile · Denzlingen, DE
Philipp Wolf · Gundelfingen, DE
Dorothee Gierschner · Teningen, DE
Patrick Bühler · Glückstadt, DE
Ulrich Wetterauer · Glückstadt, DE

Key dates

Filing date	May 8, 2012
Grant date	Jan 21, 2014
Priority date	—
Expiry date	May 8, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Isolated monoclonal antibodies or an antigen binding portion thereof which bind to prostate specific membrane antigen in its native form occurring on the surface of tumor cells characterized in that it is linked to a label or a cytotoxic agent or constructed as a part of a bispecific antibody or a recombinant diabody.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.